Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018)

Amneal Pharmaceuticals (AMRX) posted quarterly FCF Payout Ratio of 1.32 for Q2 2018, down 133.2% quarter-over-quarter from 3.98 in Q1 2018.

Amneal Pharmaceuticals (AMRX) FCF Payout Ratio (2017 - 2018) Analysis & Trends

Amneal Pharmaceuticals' FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 1.32 for Q2 2018.

In Q2 2018, FCF Payout Ratio changed N/A year-over-year to 1.32; the TTM figure through Mar 2019 stood at 4.61 (changed N/A YoY), while the FY2018 annual figure was 1.09, down 59.32% from the prior year.
FCF Payout Ratio for Q2 2018 stood at 1.32, down from 3.98 in the prior quarter.
The five-year high for FCF Payout Ratio was 3.98 in Q1 2018, with the low at 1.32 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.41
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-0.83
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.42
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Amneal Pharmaceuticals	5.70 Bn	5.57 Bn	334.51 Mn	-

Download Data